# The Collapse of the Collagen Sponge Microstructure Triggers an Inflammatory Response of Macrophages via the Itgαvβ3/5-Src-RhoC-NF-κB Axis

**Authors:** Zefeng Guo, Mengxi Su, Meihua Mai, Tianze Lin, Xinyi Yang, Shiyu Wu, Zhuofan Chen

PMC · DOI: 10.3390/bioengineering13020210 · Bioengineering · 2026-02-12

## TL;DR

This study shows how different cross-linking methods affect collagen sponges' structure and inflammation in macrophages.

## Contribution

The study identifies a specific signaling pathway triggered by microstructural collapse in collagen sponges.

## Key findings

- TG-cross-linked sponges caused macrophage activation via the Itgαvβ3/5-Src-RhoC-NF-κB axis.
- EDC/NHS-cross-linked sponges maintained structure and suppressed inflammation.
- Findings suggest design principles for low-inflammatory collagen biomaterials.

## Abstract

Collagen sponges are widely used for oral tissue regeneration, due to their extracellular matrix-mimetic architecture and excellent biocompatibility. However, in practical biomedical applications, collagen sponges may exhibit hydration-induced structural instability, and there can be associated inflammatory responses under physiological conditions, potentially compromising their regenerative performance. In this study, we investigated how two cross-linking strategies—transglutaminase (TG) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-hydroxysuccinimide (EDC/NHS)—modulate the structural stability and inflammatory profiles of collagen sponges. TG-cross-linked sponges exhibited microstructural collapse, associated with macrophage activation and engagement of the Itgαvβ3/5–Src–RhoC–NF-κB signaling axis. In contrast, EDC/NHS-cross-linked sponges preserved a stable porous architecture, effectively suppressing this signaling cascade and establishing a low-inflammatory microenvironment. These findings elucidate a key mechanism by which cross-linking regulates the microstructural integrity of collagen scaffolds and provides in vitro-derived preliminary design principles for developing next-generation collagen biomaterials with low-inflammatory properties.

## Linked entities

- **Genes:** SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714], RHOC (ras homolog family member C) [NCBI Gene 389], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Chemicals:** 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (PubChem CID 15908), N-hydroxysuccinimide (PubChem CID 80170)

## Full-text entities

- **Genes:** Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Src (src proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 20779] {aka pp60c-src}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Ptk2 (PTK2 protein tyrosine kinase 2) [NCBI Gene 14083] {aka FADK 1, FAK, FRNK, Fadk, p125FAK}, Rhoc (ras homolog family member C) [NCBI Gene 11853] {aka Arh9, Arhc}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Itgb3 (integrin beta 3) [NCBI Gene 16416] {aka CD61, GP3A, INGRB3}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Cd40 (CD40 antigen) [NCBI Gene 21939] {aka Bp50, GP39, HIGM1, IGM, IMD3, T-BAM}, Itgb5 (integrin beta 5) [NCBI Gene 16419] {aka ESTM23, [b]-5, [b]5, [b]5A, [b]5B, beta-5}, Pphln1 (periphilin 1) [NCBI Gene 223828] {aka CR, HSPC206, HSPC232}, RHOC (ras homolog family member C) [NCBI Gene 389] {aka ARH9, ARHC, H9, RHOH9}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Il1rn (interleukin 1 receptor antagonist) [NCBI Gene 16181] {aka F630041P17Rik, IL-1ra}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Itgav (integrin alpha V) [NCBI Gene 16410] {aka 1110004F14Rik, 2610028E01Rik, CD51, D430040G12Rik}, Itga7 (integrin alpha 7) [NCBI Gene 16404] {aka [a]7, alpha7}
- **Diseases:** osteoclast (MESH:D001862), Inflammatory (MESH:D007249), injury to (MESH:D014947), Cytotoxicity (MESH:D064420), macrophage (MESH:D055501)
- **Chemicals:** Ethanol (MESH:D000431), sodium hydroxide (MESH:D012972), biotin (MESH:D001710), acetic acid (MESH:D019342), TRIzol (MESH:C411644), Distilled Water (MESH:D014867), N-hydroxysuccinimide (MESH:C001426), E (MESH:D004540), C (MESH:D002244), streptomycin (MESH:D013307), N (MESH:D009584), phosphate (MESH:D010710), salt (MESH:D012492), O (MESH:D010100), platinum (MESH:D010984), sodium chloride (MESH:D012965), EDC (MESH:C024565), glutaraldehyde (MESH:D005976), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (MESH:D005022), 60Co (MESH:C000615395), lipids (MESH:D008055), CO2 (MESH:D002245), tert-butanol (MESH:D020002), disodium hydrogen phosphate dodecahydrate (MESH:C018279), penicillin (MESH:D010406), Amide II (-), S (MESH:D013455)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), CL-0190 — Homo sapiens (Human), Transformed cell line (CVCL_K455)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937798/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937798/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937798/full.md

---
Source: https://tomesphere.com/paper/PMC12937798